SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 181.46-2.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (21578)5/31/1998 4:24:00 PM
From: TomOrt  Read Replies (2) of 32384
 
A quote from Michael Murphy's "Every Investor's
Guide to High Tech Stocks & Mutual Funds".

"The mark up from Phase III to functioning
pharmaceutical co. with approved products is even
larger. These co's have an average market cap. of
$3 billion. So investors average a 10-1 return from
Phase III to an approved, successful drug.

"The two reasons the markup is so large are, first,
because there are many investors that will not or, by
prospectus, cannot buy development-stage, unprofitable
companies. They jump on when the profits start to flow.
Second, the pharmaceutical business is extremely
profitable and not cyclical........"

I would like to see $25.00 this summer, but what
I am looking forward to, ( in spite of the day to day
disappointments ) is what I expect LGND to be worth
in five years. when I turn 59 1/2 and can tap my IRA.

Good luck to all, go Ligand; TomOrt
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext